Category Archives: Mammoplasty

Glossary of Cosmetic Surgery Terms | Costhetics

Belly Button Rejuvenation

A cosmetic surgical procedure that changes the size, shape or position of the belly button to improve the aesthetics of the abdomen. The procedure is also known as belly button reshaping and umbilicoplasty.

A cosmetic surgical procedure that changes the size, shape or position of the belly button to improve the aesthetics of the abdomen. The procedure is also known as belly button rejuvenation and umbilicoplasty.

A surgical procedure that removes fat and excess skin from the upper and lower eyelids. Also referred to as eyelid surgery. See our article oneyelid surgery for more information.

A condition in which a person feels such an excessive concern over their appearance that it interferes with daily life.

A surgical procedure that reduces excess skin and fat from the underarm area. Also known as an arm lift. See the procedure article on arm lift surgery for more information.

A surgical procedure that increases the size of the breasts by inserting breast implants. See the procedure article on breast augmentation for more information.

Prostheses made of either a fluid (saline) or a gel-like material (silicone) that is placed under or over the pectoral muscle during a breast augmentation. Implants come in various shapes, sizes and textures. See breast augmentation for more information. Also see saline implants and silicone implants.

Sometimes combined with breast augmentation, a breast lift is a surgical procedure to lift sagging breasts. Also referred to as mastopexy. See our breast lift article for more information.

A series of surgical procedures aiming to rebuild a naturally contoured breast after breast removal surgery. It is also an option for women with breast abnormalities or who have suffered trauma to the breasts. For more information see our article on breast reconstruction surgery.

Also known asreduction mammoplasty.A surgical procedure to reduce breast size and to relieve the discomfort of having unusually large breasts. See ourarticle on breast reductionfor more information.

A surgical procedure, which involves the removal of one or both breasts, either fully or partially. Also referred to as mastectomy.

An inflatable breast implant that is designed to stretch the skin and muscle to make room for a more permanent implant at a future date.See ourarticle on Tissue Expanders for Breast Reconstructionfor more information.

A surgical procedure that minimises wrinkles by lifting the muscles and tissue of the area above the eyebrows. See the procedure article on brow lifts for more information.

A surgical procedure that reshapes the cheeks through the removal of fat. Also referred to as cheek reduction. See our article on cheek reduction for more information.

A surgical procedure used to enhance the buttock area by enlarging, lifting and shaping the buttocks. See our article on buttock augmentation for more information.

Read more from the original source:
Glossary of Cosmetic Surgery Terms | Costhetics

Simultaneous brachioplasty, thoracoplasty, and mammoplasty …

Body contour surgery for the patient who has experienced massive weight loss requires extensive and multiple operations. Any means of reducing the number of such procedures while obtaining optimal results would be most beneficial to both surgeon and patient. Combined brachioplasty, thoracoplasty, and mammoplasty has proven to be safe, effective, and appropriate toward achieving these goals.

Key wordsBody contouringMorbid obesity

Unable to display preview.Download preview PDF.

1.

Baroudi R: Dermatolipectomy of the upper arm. Clin Plast Surg

:485, 1975

2.

Borges AF: W-plastic dermolipectomy to correct bat-wing deformity. Ann Plast Surg.

:498, 1982

3.

Guerrero-Santos J: Brachioplasty. Aesth Plast Surg

:1, 1979

4.

Pitanguy I, Ceravolo MP: Our experience with combined procedures in aesthetic plastic surgery. Plast Reconstr Surg

:56, 1983

5.

Pitanguy I: Correction of lipodystrophy of the lateral thoracic aspect and inner side of the arm and elbow dermosenescence. Clin Plast Surg

:477, 1975

6.

Regnault P: Brachioplasty, axilloplasty, and pre-axilloplasty. Aesth Plast Surg

:31, 1983

7.

Wise RJ: A preliminary report on a method of planning the mammaplasty. Plast Reconstr Surg

:367, 1956

8.

Zook EG: The massive weight loss patient. Clin Plast Surg

:457, 1975

Springer-Verlag1985

Read more from the original source:
Simultaneous brachioplasty, thoracoplasty, and mammoplasty …

Here’s How Long Transgender Troops Are Nondeployable, Depending on Medical Needs – Independent Journal Review

U.S. Department of Defense/Flickr

A study commissioned by the Obama administration shows how longa transgender service member could benondeployable, depending on what type of treatment they receive.

The study was conducted by the Rand Corp. in preparation for transgender troops being able to serve openly at the order of then-Secretary of DefenseAsh Carter.

The study takes into accountthe estimated recovery time and the amount of medical and medical disability leave they could need. For minor treatments such as hormone therapy, there is no recovery time.

For male troops transitioning to female, if they get augmentation mammoplasty, theestimated recovery time is one week of no work and four-to-sixweeks of restricted physical activity. They will be nondeployable for around 75 days.

If they opt for genital surgery, the recovery time is four-to-six weeks of no work and more than eight weeks of restricted physical activity. The transitioned troops will be nondeployable for 135 days.

For females transitioning to males, if they choose to get a hysterectomy, they will be nondeployable for at least 111 days.

Screenshot/Rand Corp.

The nondeployability numbers take the amount medical leave the troops can take as a result of the different medical options, which can be up to 90 days for the major options.

The study concedes the numbers do not take into account the different branches’ guidelines on deployability:

We note that these estimates do not account for any additional time required to determine medical fitness to deploy. Army guidelines, for example, do not permit deployment within six weeks of surgery. Nevertheless, there may be a significant difference between the estimated availability to deploy and the actual impact on deployability, as it is possible that transgender service members would time their medical treatments to minimize the effect on their eligibility to deploy.

Estimates derived from survey data and private health insurance claims data indicate that, each year, between 29 and 129 service members in the active component will seek transition-related care that could disrupt their ability to deploy, the study added.

The U.S. Department of Defense will take deployability into account when implementing President Donald Trump’s new ban on transgender people serving in the military and using it as the primary legal means to decide whether to separate service members from the military, according to The Wall Street Journal.

Link:
Here’s How Long Transgender Troops Are Nondeployable, Depending on Medical Needs – Independent Journal Review

Bonti begins LANTERN-1 phase II study evaluating EB-001 in reducing musculoskeletal pain – pharmabiz.com

Bonti, a privately-held, clinical-stage biotechnology company, announced the initiation of its LANTERN clinical programme aimed at relieving musculoskeletal pain and reducing use of opioids using its neurotoxin platform. The first clinical study, LANTERN-1, one of two phase 2 clinical studies, is a placebo-controlled, double-blind ascending dose cohort trial to evaluate the safety and efficacy of EB-001 intramuscular (IM) injections in subjects undergoing elective augmentation mammoplasty (breast augmentation).

EB-001 is a novel serotype E botulinum neurotoxin (BoNT/E) with a unique product profile, characterized by fast onset of action (about 24 hours) and short duration of effect (about 4 weeks). Leveraging the benefits of this profile, Bonti is developing products to pursue areas of unmet medical need with significant addressable market opportunities.

The recent successful completion of a proof of concept Phase 2A clinical study established efficacious and safe doses of EB-001 in the treatment of glabellar (frown) lines. Dosing data from that study confirmed dose selection for the LANTERN Phase 2 studies. The LANTERN-1 study is a single intra-operative treatment of EB-001 IM injections into the pectoralis major (PM) which will be administered in subjects undergoing breast augmentation. The primary outcome measure is the subjects assessment of pain using the Numeric Pain Rating Scale (NPRS). Interim clinical results from the LANTERN-1 Phase 2 study are expected by year-end 2017.

We are excited about the commencement of our LANTERN clinical program. As a locally administered biologic, EB-001 has the potential to address pain without the addiction risks or the side effects of current analgesic treatments, commented Fauad Hasan, co-founder and CEO at Bonti. The start of this Phase 2 study is a significant milestone toward successfully establishing EB-001 as a long-acting, non-opioid solution for the treatment of focal musculoskeletal pain. Our aim is to make EB-001 available as quickly as possible to help address the opioid epidemic affecting millions in the U.S. annually.

Countless people experience musculoskeletal pain due to surgery, overuse (wear and tear) or other injury of muscles, causing muscle spasms and hyperactivity. Pain reaches extremes after many surgical procedures and in other medical conditions when it results from incised and stretched muscles or muscle tension. Current pain relief medications such as systemic opioids and muscle relaxants and even locally administered anesthetics only mask symptoms and fail to treat the muscle hyperactivity, muscle spasms and muscle contraction which are root causes of pain.

EB-001 has the potential to be one of the most meaningful pain management advances in decades for post-surgical and non-surgical care where opioids have long been the standard of care because of their efficacy, despite their side effects and risks, added Valerie Lemaine, MD, MPH, Assistant Professor of Plastic Surgery at Mayo Clinic in Rochester, Minnesota and a Bonti advisor. As a surgeon, I seek to provide my patients the best outcomes possible so they recover as rapidly and comfortably as possible and EB-001 has the promise to help me achieve this goal while helping stem the crisis we currently face with opioids. EB-001s fast onset and short duration target profile will make a promising addition to our multi-modal pain relief options for pain management following breast surgeries.

The LANTERN (Long-Acting NeuroToxin-E Relief, Non-opioid) clinical programs key objective is to support Bontis strategy of seeking broad label approval of EB-001 for the treatment of focal musculoskeletal pain. This requires conducting two successful registration trials in two different musculoskeletal models starting with Phase 2 studies LANTERN-1 (Breast Augmentation) and LANTERN-2 (Abdominoplasty).

Bontis lead product candidate, EB-001, is an investigational botulinum neurotoxin serotype E (BoNT/E). EB-001 has a mechanism of action similar to the marketed botulinum neurotoxin serotype A (BoNT/A) products though it has a differentiated clinical profile. EB-001 has a fast onset of action (about 24 hours) and short duration of effect (about 4 weeks). Currently marketed BoNT/A products have an onset of action around 3-7 days and a duration of effect around 3-4 months. The unique target clinical profile of EB-001 is well suited for a vast range of aesthetic and therapeutic uses, including for the treatment of post-surgical and non-surgical musculoskeletal pain, with currently unmet needs.

Read more:
Bonti begins LANTERN-1 phase II study evaluating EB-001 in reducing musculoskeletal pain – pharmabiz.com

Average Transgender Soldier Unable to Deploy for 238 Days – Washington Free Beacon

Getty Images

BY: Elizabeth HarringtonAugust 24, 2017 1:20 pm

The average transgender soldier will spend 238 days recovering from sex change surgeries and unavailable to deploy, according to an Obama administration study.

The Trump administration’s transgender ban places deployability as a determining factor into whether to admit transgender individuals into the military. The White House outlined guidelines to implement the ban within six months in a memo to Defense Secretary Jim Mattis, the Wall Street Journal reported Wednesday.

The ability to be deployed to war zones or bases around the world is an issue for transgender soldiers who undergo taxpayer-funded sex change operations, according to a study by the RAND Corporation.

The 2016 study was commissioned by the Obama administration, which favored opening the ranks to transgender individuals, and funded by the office of former secretary of defense Ash Carter.

The study found that, on average, transgender troops seeking basic sex-change operations would be nondeployable for 238 days, or 34 weeks out of a year. The figure amounts to 65 percent of one year.

“These constraints typically include a postoperative recovery period that would prevent any work and a period of restricted physical activity that would prevent deployment,” the RAND study states.

“We note that these estimates do not account for any additional time required to determine medical fitness to deploy,” the RAND study added. “Army guidelines, for example, do not permit deployment within six weeks of surgery.”

The RAND study reported that male-to-female surgeries would cost 210 days of nondeployability, including medical leave and medical disability periods.

Breast augmentation and mammoplasty, which can include breast implants, would result in troops being unable to work for one week, up to six weeks of restricted physical activity, and up to 60 days of medical disability. The RAND study said breast augmentation would result in 75 days a servicemember could not be deployed.

Genital surgeries require a longer recovery period. RAND reported that a transgender person getting an orchiectomy, the surgical removal of the testicles, or a vaginoplasty, the construction of a vagina, would be nondeployable for 135 days.

Nondeployable time for male-to-female genital surgeries includes four to six weeks of no work; eight-plus weeks restricted physical activity; up to 45 days medical leave; and up to 90 days medical disability.

Sue Fulton, the former president of Sparta, a military organization for LGBTQ individuals, told the Wall Street Journal that transgender individuals are “just as deployable as other service members,” and compared the time off to undergoing a gall bladder surgery.

“Other service members may undergo procedures when they are at home base, just as other service members schedule shoulder surgery or gall bladder surgery,” she said.

Most people return to normal activities 7 to 10 days after undergoing gall bladder surgery.

The RAND study also notes some individuals undergoing sex-change operations “experience postoperative complications that would render them unfit for duty.”

The study states that between 6 to 20 percent of biological males receiving a vaginoplasty, or the construction of a vagina, have complications. Up to 25 percent of biological females receiving phalloplasty surgery, or the construction of a penis, have medical complications, RAND said.

RAND found female-to-male transitions on average take longer recovery times, on average 267 days where they cannot be deployed.

The RAND study reported chest surgery, removal of the breasts, results in 75 days of nondeployability, and a hysterectomy leads to 111 days of nondeployability, including three weeks of medical leave and three months of medical disability.

Genital surgeries for female-to-male, including metoidioplasty, a surgery that enlarges the clitoris to surgically create a penis, and phalloplasty, the construction of a penis, result in 81 days of nondeployable time.

Rep. Vicky Hartzler (R., Mo.), who supports President Donald Trump’s action to ban transgender individuals in the military, says the RAND Corporation estimates are low, because they do not take into account other surgeries that transgender advocates say are “medically necessary.”

The World Professional Association for Transgender Health deems other medical procedures, including scrotoplasty, surgery to create a scrotum, facial hair removal, facial plastic reconstruction, hair removal, and voice therapy or surgery, as medically necessary for Gender Dysphoria.

Using the RAND study estimates, Hartzler’s office found a significant period of total nondeployable time based on the estimates of how many transgender troops would seek sex reassignments.

As the Washington Free Beacon previously reported, transgender surgeries would cost the Pentagon $1.3 billion over 10 years, assuming roughly 8,200 transgender troops undergo taxpayer-funded sex-change operations.

By taking the low estimate from the RAND study of nondeployable time of 210 days, the 8,213 surgical transitions would lead to a total 1,724,730 days of nondeployable time, or 4,725 years.

RAND recommended that the military allow transgender individuals to serve openly and estimated that transgender surgeries would only cost between $2.4 million to $8.4 million per year.

Given that transgender surgeries cost an average of $132,000, according to CNN, the RAND study assumes only 18 to 63 transgender troops would seek taxpayer-funded surgeries.

The RAND cost estimate is significantly lower because it does not account for actual costs of transgender surgeries, but only the cost increase in private health insurance premiums for plans that cover transgender services. The military does not have private health insurance.

The White House directive to Secretary Mattis mainly applies to new recruits and gives the Pentagon the discretion of expelling current transgender service members based on deployability. The memo also instructs the Pentagon to stop paying for transgender medical treatment for those currently serving.

See more here:
Average Transgender Soldier Unable to Deploy for 238 Days – Washington Free Beacon

New report shares details about the competitive landscape for global breast implant market – WhaTech

The procedure involves the use of breast implants and fat, called as fat transfer breast augmentation, in order to enhance and improve the size of the breasts. In clinical terms, breast augmentation is referred as augmentation mammoplasty.

The primary customer base for breast augmentation are women belonging to middle- and high-income families. The World Bank estimates that the global annual disposable income per capita for women is expected to increase at a CAGR of approximately 6% in the next few years, driving the expansion of the aesthetic market globally.

Additionally, significant rise of the worlds middle-class population over the last few years, resulting in increase in purchasing power and discretionary spending, is indicative of the stability and growth of the global breast implant market. It has been estimated that much of this growth in purchasing power is likely to come from emerging markets, which is attributed to rising disposable income.

Obtain Report Details atwww.transparencymarketresearch.com/breast-implant-market.html

Rise in global disposable income and growth in reimbursement rates for reconstructive procedures are expected to propel the market growth for breast implant during the forecast period. In addition, availability of premium-priced products, expansion of product portfolio, and increase in prevalence of breast cancer are factors driving the global market growth for breast implant.

As per data released by the World Health Organization (WHO), in 2012, 1.7 million women were diagnosed with breast cancer, leading to approximately 522,000 deaths during the same year. Hence, increase in breast cancer prevalence is a major factor contributing to revenue growth of the breast implant market across the globe.

However, risk of developing serious complications and lack of skilled nursing facilities in developing regions may hamper the market share. Large amount of documented evidences supporting the possibility of developing breast cancer after getting breast implants is one of the prime reasons hampering the growth of the market.

In 2011, FDA indicated possible association between breast implants (saline and silicone) and anaplastic large-cell lymphoma (ALCL). Anaplastic large-cell lymphoma is a rare type of non-Hodgkins lymphoma (NHL), characterized by abnormal growth of T-lymphocytes.

According to the National Cancer Institute, the disease affects 1 in 500,000 women globally. However, in the U.S., ALCL affects 3 in 100 million women who have undergone breast implants surgery.

The global breast implant market is segmented on the basis of implant type, application, end-user, and region. Based on implant type, the market is categorized into saline breast implants and silicone breast implants.

The silicone breast implants segment is expected to account for a significant share of the market in the near future. The large share of the segment are attributed to comparatively less adverse reactions associated with it, availability of expanded product line, and premium-priced products.

On the basis of application, the market is divided into cosmetic surgery and reconstructive surgery. Breast augmentation remains one of the top cosmetic surgical procedures globally; hence, the cosmetic surgery segment held a major share of the market in 2016 and the trend is expected to continue in the near future.

Rise in emphasis on physical appearance and studies reporting increased self-esteem and confidence in women with cosmetic breast augmentation are expected to drive the growth of the market for breast implant in cosmetic applications. Further, adoption of reconstructive surgery is expected to increase significantly in women undergoing mastectomy.

On the basis of end-user, the market is segmented into hospitals, dermatology clinics & cosmetic centers, and ambulatory surgical centers. The hospitals segment is expected to be the most attractive end-user segment of the market during the forecast period owing to the rising popularity of surgical procedures that are performed in hospitals rather than cosmetology clinics.

According to the International Society of Aesthetic Plastic Surgery, majority of surgical procedures are performed in hospitals accounting for approximately 66.5% share of the global market.

Based on geography, the market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global breast implant market during the forecast period owing to rise in awareness and adoption of various silicone breast implant services, growth in health care infrastructure, and increase in incidence of breast cancer.

Key players operating in the market include Allergan, Plc, Mentor Worldwide LLC, GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., CEREPLAS, and HansBiomed Co. Ltd.

Report:www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22895

See original here:
New report shares details about the competitive landscape for global breast implant market – WhaTech

Breast Implant Market – Global Industry Volume and Region Analysis – 2025 – Digital Journal

Transparency Market Research Report Added “Breast Implant Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”

This press release was orginally distributed by SBWire

Albany, NY — (SBWIRE) — 07/31/2017 — Breast implants are medical devices that are used to augment the size of breasts, either for cosmetic applications or reconstruction purpose, following mastectomy or to correct a congenital abnormality. Breast augmentation, commonly known as breast enlargement, is a popular surgical procedure that improves the size and shape of the breast. The procedure involves the use of breast implants and fat, called as fat transfer breast augmentation, in order to enhance and improve the size of the breasts. In clinical terms, breast augmentation is referred as augmentation mammoplasty. According to a statistics by American Society of Plastic Surgeons (ASPS), the average cost of a breast augmentation surgery was US$ 3,708 in 2014. Socioeconomic status is a primary factor creating a high demand for breast implants globally. The primary customer base for breast augmentation are women belonging to middle- and high-income families. The World Bank estimates that the global annual disposable income per capita for women is expected to increase at a CAGR of approximately 6% in the next few years, driving the expansion of the aesthetic market globally. Additionally, significant rise of the world’s middle-class population over the last few years, resulting in increase in purchasing power and discretionary spending, is indicative of the stability and growth of the global breast implant market. It has been estimated that much of this growth in purchasing power is likely to come from emerging markets, which is attributed to rising disposable income.

Obtain Report Details @http://www.transparencymarketresearch.com/breast-implant-market.html

Rise in global disposable income and growth in reimbursement rates for reconstructive procedures are expected to propel the market growth for breast implant during the forecast period. In addition, availability of premium-priced products, expansion of product portfolio, and increase in prevalence of breast cancer are factors driving the global market growth for breast implant. As per data released by the World Health Organization (WHO), in 2012, 1.7 million women were diagnosed with breast cancer, leading to approximately 522,000 deaths during the same year. Hence, increase in breast cancer prevalence is a major factor contributing to revenue growth of the breast implant market across the globe. However, risk of developing serious complications and lack of skilled nursing facilities in developing regions may hamper the market share. Large amount of documented evidences supporting the possibility of developing breast cancer after getting breast implants is one of the prime reasons hampering the growth of the market. In 2011, FDA indicated possible association between breast implants (saline and silicone) and anaplastic large-cell lymphoma (ALCL). Anaplastic large-cell lymphoma is a rare type of non-Hodgkin’s lymphoma (NHL), characterized by abnormal growth of T-lymphocytes. According to the National Cancer Institute, the disease affects 1 in 500,000 women globally. However, in the U.S., ALCL affects 3 in 100 million women who have undergone breast implants surgery.

The global breast implant market is segmented on the basis of implant type, application, end-user, and region. Based on implant type, the market is categorized into saline breast implants and silicone breast implants. The silicone breast implants segment is expected to account for a significant share of the market in the near future. The large share of the segment are attributed to comparatively less adverse reactions associated with it, availability of expanded product line, and premium-priced products. On the basis of application, the market is divided into cosmetic surgery and reconstructive surgery. Breast augmentation remains one of the top cosmetic surgical procedures globally; hence, the cosmetic surgery segment held a major share of the market in 2016 and the trend is expected to continue in the near future. Rise in emphasis on physical appearance and studies reporting increased self-esteem and confidence in women with cosmetic breast augmentation are expected to drive the growth of the market for breast implant in cosmetic applications. Further, adoption of reconstructive surgery is expected to increase significantly in women undergoing mastectomy.

On the basis of end-user, the market is segmented into hospitals, dermatology clinics & cosmetic centers, and ambulatory surgical centers. The hospitals segment is expected to be the most attractive end-user segment of the market during the forecast period owing to the rising popularity of surgical procedures that are performed in hospitals rather than cosmetology clinics. According to the International Society of Aesthetic Plastic Surgery, majority of surgical procedures are performed in hospitals accounting for approximately 66.5% share of the global market.

Based on geography, the market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global breast implant market during the forecast period owing to rise in awareness and adoption of various silicone breast implant services, growth in health care infrastructure, and increase in incidence of breast cancer.

Key players operating in the market include Allergan, Plc, Mentor Worldwide LLC, GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., CEREPLAS, and HansBiomed Co. Ltd.

Fill the form for an exclusive sample of this report @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22895

About Transparency Market ResearchTransparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

ContactTransparency Market Research90 State Street, Suite 700Albany, NY 12207Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.comBrowse market research blog: https://tmrresearch.blogspot.com/

For more information on this press release visit: http://www.sbwire.com/press-releases/breast-implant-market-global-industry-volume-and-region-analysis-2025-841442.htm

Original post:
Breast Implant Market – Global Industry Volume and Region Analysis – 2025 – Digital Journal

Sample Consent Form: Reduction Mammoplasty, infection …

INSTRUCTIONS

This is an informed-consent document that has been prepared to help your plastic surgeon tell you about breast reduction surgery, its risks, and alternative treatments. It is important that you read this information carefully and completely. Please initial each page, indication that you have read the page and sign the consent as proposed by your plastic surgeon.

Women who have large breasts may experience a variety of problems from the weight and size of their breasts, such as back, neck, and shoulder pain, and skin irritation. Breast reduction is usually performed for relief of these symptoms and not to enhance the appearance of the breasts. The best candidates are those who are mature enough to understand the procedure and have realistic expectations about the results. There are a variety of different surgical techniques used to reduce and reshape the female breast. There are both risks and complications associated with breast reduction surgery.

Breast reduction is an elective surgical operation. Alternative treatment would consist of not undergoing the surgical procedure, physical therapy to treat pain complaints, or wearing undergarments to support large breast. In selected patients, liposuction has been used to reduce the size or large breasts. Risks and potential complications are associated with alternative surgical forms of treatment.

Every surgical procedure involves a certain amount of risk. It is important that you understand the risks involved with breast reduction. An individuals choice to undergo a surgical procedure is based on the comparison of the risk to potential benefit. Although the majority of women do not experience the following complications, you should discuss each of them with your plastic surgeon to make sure you understand the risks, potential complications and consequences of breast reduction.

Bleeding It is possible, though unusual, to experience a bleeding episode during or after surgery. Should post-operative bleeding occur, it might need emergency treatment to drain accumulated blood or blood transfusion. Do not take any aspirin or anti-inflammatory medications for ten days before surgery, as this may increase the risk of bleeding.

Infection An infection is quite unusual after this type or surgery. Should an infection occur treatment including antibiotics or more surgery may be necessary.

Change in nipple and skin sensation You may experience a change in the sensitivity of the nipples and the skin of your breast. Permanent loss of nipple sensation can occur after a breast reduction in one or both nipples.

Skin scarring All surgical incisions produce scarring. The quality of these scars is unpredictable. Abnormal scars may occur within the skin and deeper tissue. In some cases, scars may need surgical revision or other treatments.

Unsatisfactory result There is the possibility of a poor result from the breast reduction surgery. You may be disappointed with the size and shape or your breasts.

Pain A breast reduction may not improve complaints of musculoskeletal pain in the neck, back and shoulders. Abnormal scarring in skin and the deeper tissues of the breast may produce pain.

Firmness Excessive firmness of the breast can occur after surgery due to internal scarring or fat necrosis. The occurrence of this is not predictable. If an area of fat necrosis or scarring appears, this may need biopsy or added surgical treatment.

Delayed healing Wound disruption or delayed wound healing is possible. Some areas of the breast skin or nipple region may not heal normally and may take a long time to heal. It is even possible to have loss of skin or nipple tissue. This may need frequent dressing changes or further surgery to remove the non-healed tissue. Smokers have a greater risk of skin loss and wound healing complications.

Asymmetry Some breast asymmetry naturally occurs in most women. Differences in breast and nipple shape, size, and symmetry may also occur after surgery. Additional surgery may be necessary to revise asymmetry after a breast reduction.

Breast disease Breast disease and breast cancer can occur independently of breast reduction surgery. It is recommended that all women do periodic self-examination of their breasts, have mammography according to American Cancer Society guidelines, and to seek professional care should a breast lump be detected.

Breast-feeding Although some women have been able to breast feed after breast reduction. In general this is not predictable. If you are planning to breast feed following breast reductions, it is important that you discuss this with your plastic surgeon before undergoing breast reduction.

Allergic reactions In rare cases, local allergies to tape, suture material, or topical preparations have been reported. Systemic reactions, which are more serious, may occur to drugs used during and prescription medicines. Allergic reactions may need more treatment.

Surgical anesthesia both local and general anesthesia involve risk. There are possibility of complications, injury, and even death from all forms of surgical anesthesia or sedation.

There are many variable conditions that may influence the long-term result of breast reduction. Secondary surgery may be necessary to do more tightening or repositioning of the breasts. Should complications occur, added surgery or other treatments may be necessary. Even though risks and complications occur infrequently, the risks cited are particularly associated with breast reduction surgery. Other risks and complications can occur but are even more uncommon. The practice of medicine and surgery is not an exact science. Although good results are expected, there is no guarantee or warranty expressed or implied, on the result that may be obtained.

Depending on your particular health insurance plan, breast reduction surgery may be considered a covered benefit. There may be other requirements in terms of the amount of breast tissue to be removed and duration of physical problems caused by large breasts. Breast reductions involving removal of small amount s of tissue may not be covered by your insurance. Please check your health insurance subscriber-information pamphlet, call your insurance company, and discuss this further with your plastic surgeon. Many insurance plans exclude coverage for secondary or revisionary surgery.

The cost of surgery involves several charges for the services provided. The total includes fess charged by your doctor, the cost of surgical supplies, laboratory test, anesthesia, and outpatient hospital charges, depending on where the surgery is performed. Depending on whether the cost of surgery is covered by an insurance plan, you will be responsible for necessary co-payments, deductibles, and charges not covered. Additional costs may occur should complications develop from the surgery. Secondary surgery or hospital day surgery charges involved with revisionary surgery would be your responsibility.

Deep Venous Thrombosis, Cardiac and Pulmonary Complications: Surgery, especially longer procedures, may be associated with the formation of, or increase in, blood clots in the venous system. Pulmonary complications may occur secondarily to blood clots (pulmonary emboli), fat deposits (fat emboli) or partial collapse of the lungs after general anesthesia. Pulmonary and fat emboli can be life threatening or fatal in some circumstances. Air travel, inactivity and other conditions may increase the incidence of blood clots travelling to the lungs causing a major blood clot that may result in death. It is important to discuss with your physician any history of blood clots or swollen legs that may contribute to this condition. Cardiac complications are a risk with any surgery and anesthesia, even in patients without symptoms. If you experience shortness of breath, chest pain or unusual heartbeats, seek medical attention immediately. Should any of these complications occur, you might require hospitalization and more treatment.

Smoking, Second-Hand Smoke Exposure, Nicotine Products (Patch, Gum, Nasal Spray): Patients who are now smoking, use tobacco products, or nicotine products (patch, gum or nasal spray) are at a greater risk for significant surgical complications of skin dying, delayed healing and added scarring. Individuals exposed to second-hand smoke are also at potential risk for similar complications attributable to nicotine exposure. Additionally, smokers may have a significant negative effect on anesthesia and recovery from anesthesia, with coughing and possibly increased bleeding. Individuals who are not exposed to tobacco smoke or nicotine-containing products have a lower risk of this type of complication. Please write your current status about these items below:

_______ I am a non-smoker and do not use nicotine products. I understand the risk of second-hand smoke exposure causing surgical complications.

_______ I am a smoker or use tobacco/ nicotine products. I understand the risk of surgical complications due to smoking or use of nicotine products.

It is important to refrain from smoking at least 6 weeks before surgery and until your physician states it is safe to return, if desired.

Female Patient Information: It is important to tell your plastic surgeon if you use birth control pills, estrogen replacement, or if you believe you may be pregnant. Many medications including antibiotics may neutralize the preventive effect of birth control pills, allowing for conception and pregnancy.

Intimate Relations After Surgery: Surgery involves coagulating of blood vessels and increased activity of any kind may open these vessels leading to a bleed, or hematoma. Increased activity that increased your pulse or heart rate may cause more bruising, swelling and the need for return to surgery and control of bleeding. It is wise to refrain from physical intimacy activity until your physician states it is safe.

Medications: There are many adverse reactions that occur as the result of taking over the counter, herbal, and/or prescription medications. Be sure to check with your physician about any drug interactions that may exist with medications that you are already taking. If you have an adverse reaction, stop the drugs immediately and call your plastic surgeon for further instructions. If the reaction is severe, go immediately to the nearest emergency room. When taking the prescribed pain medications after surgery, realize that they can affect your thought process. Do not drive, do not use complex equipment, do not make any important decisions and do not drink any alcohol while taking these medications. Be sure to take your prescribed medication only as directed.

Follow all physician instructions carefully; this is essential for the success of your outcome. It is important that the surgical incisions are not subjected to excessive force, swelling, abrasion, or motion during the time of healing. Personal and vocational activity needs to be restricted. Protective dressings and drains should not be removed unless instructed by your plastic surgeon. Successful post-operative function depends on both surgeryand later care. Physical activity that increases your pulse or heart rate may cause bruising, swelling, fluid accumulation around implants and the need for the return to surgery. It is important that you take part in follow-up care, return for aftercare, and promote your recovery after surgery.

I hereby authorize Dr. ___________________ and such assistants as may be selected to do the following procedure or treatment: I have received the following information sheet: INFORMED CONSENT for BREAST REDUCTION SURGERY

1 I recognize that during the course of the operation and medical treatment or anesthesia, unforeseen conditions may need different procedures than those above. I therefore authorize the above physician and assistants or designees to do such other procedures that are in the exercise of his or her professional judgment necessary and desirable. The authority granted under this paragraph shall include all conditions that need treatment and are not know to my physician when the procedure is begun.

2. I consent to the administration of such anesthetics considered necessary or advisable. I understand that all forms of anesthesia involve risk and the possibility of complications, injury, and sometimes death.

3. I acknowledge that no guarantee has been given by anyone as to the results that may be obtained.

4. I consent to the photographing or televising of the operation(s) or procedure(s) to be performed, including proper portions of my body, for medical, scientific or educational purposes, provided my identity is not revealed by the pictures.

5. For purposes of advancing medical education, I consent to the admittance of observers to the operating room.

6. I consent to the disposal of my tissue, medical devices or body parts that may be removed.

7. I authorize the release of my identity card number to proper agencies for legal reporting and medical-device registration, if applicable.

8. IT HAS BEEN EXPLAINED TO ME IN A WAY THAT I UNDERSTAND: a. THE ABOVE TREATMENT OR PROCEDURE TO BE UNDERTAKEN b. THERE MAY BE ALTERNATIVE PROCEDURES OR METHODS OF TREATMENT. c. THERE ARE RISKS TO THE PROCEDURE OR TREATMENT PROPOSED I CONSENT TO THE TREATMENT OR PROCEDURE AND THE ABOVE LISTED ITEMS (1-8).

I AM SATISFIED WITH THE EXPLANATION.

__________________________________________________________________ Patient or Person Authorized to Sign for Patient/Name

Date _____________________ Witness _________________________________

Share on Facebook Share

0

Share on Pinterest Share

0

Share on Google Plus Share

0

Continue reading here:
Sample Consent Form: Reduction Mammoplasty, infection …

Breast Augmentation Surgery – Home – Edina Plastic Surgery

Breast augmentation surgery is one of the most frequently performed cosmetic procedures in the United States today. The board-certified surgeons here at Edina Plastic Surgery have a special expertise in breast augmentation. As a result, our clinic was selected to participate in the FDAs clinical trials for silicone breast implants, and we use only FDA-approved saline and silicone gel implants.

Women choose breast augmentation mammoplastybecause of breast or rib cage asymmetry, volume loss with pregnancy, mild sag or ptosis, small breast size in proportion to the rest of the body, or with breast volume loss from surgery or trauma. Placement of breast implants can increase self-esteem and confidence, improve the fit of clothing and impact gender identity. The satisfaction rate from breast augmentation surgery is extremely high.

Two types of implants are currently available and FDA-approved in the United States: saline-filled implants with a silicone elastomer shell and cohesive silicone gel filled implants with a silicone elastomer shell. The type of implant right for you will depend on your individual goals and circumstances.

A saline implantis less expensive, firmer and has more ripple potential. It can be placed with a smaller incision no matter the size of the implant and is adjustable in volume.

A silicone gel implantis more expensive, tends to be softer and shows ripples less. This implant requires a bigger incision for larger implants. It is the most natural feeling implant because the silicone gel is thicker and more similar to the consistency of body tissues.

During your initial free consultation with a surgeon at Edina Plastic Surgery,you can discuss your areas of concern and your goals for breast augmentation mammoplasty. You will receive a complete physical examination and the opportunity for virtual 3-D images of your own body showing different sizes/shapes of implants on your own frame. Edina Plastic Surgery is the only plastic surgery practice in the state using the Vectra XT 3D camera, which allows patients to see their after photos with sizing implants before surgery.

Surgeries and recoveries are more successful for patients who are as healthy and strong as possible.

> Our tips for preparing for your surgery are available here.

Three incision options are available for placement of a breast implant. Transaxillary is the first option and uses an incision in the under arm area. An endoscope is used to assist in creating the pocket for the implant. Inframammary uses an incision in the breast crease. Periareolar is the third option and uses an incision in the nipple area.

You may be a good candidate for only one or two of these breast surgery approaches or all three. There are two pocket options for the implant itself: under the pectoralis major muscle (submuscular, partial submuscular or biplanar) and under the breast gland itself (subglandular). Our surgeons have extensive experience in all of the breast augmentation incisions and both pocket placement options.

The breast augmentation surgery is conducted at our own in-house AAAASF-approved surgical facility in Minneapolis,which is state-licensed and staffed with our specialty-trained surgery team. Our surgery facility is connected to Fairview Southdale Hospital by an underground tunnel should more extensive medical care be required. One of our board-certified surgeons is on call 24/7 to answer questions and be available should the need arise.

While implant surgery is a common and safe procedure, patients need to be aware of possible risks. Some patients experience ruptures, which will occur at some point if the implants are kept long enough. Ripples, especially along the sides of the breast, may also occur especially with the saline implant. Tightening of the scar capsule surrounding the breast implant can sometimes form after surgical placement of the implant. Massaging the implant daily after surgery can lower the risk. Infection is another risk that occurs at a rate of less than 0.2% at Edina Plastic Surgery well below the national average. There can also be skin or nipple areolar sensation changes, potentially causing increased or decreased sensation.

Helping you prepare for and manage any surgery pain is a top priority. We have a variety of treatments and techniques to help make the augmentation mammoplasty as pleasant and pain-free as possible.

In some cases our surgeons may inject EXPAREL into the surgical incision. This local analgesic provides pain relief by numbing the tissue around the surgical site and can control pain for up to 72 hours. Other pain control options include the use of rapid recovery surgical techniques, muscle relaxers, appropriate pain medications and a postoperative recovery plan that gets you back to normal as soon as safely possible.

Before

After

5 2, 34 yo woman, 115 lbs. mentor moderate plus 300cc saline implant filled to 330cc on the right breast and a mentor moderate plus 325cc saline implant filled to 350cc on the left breast.

Before

After

Before

After

5 5, 27 yo woman, 125 lbs. Mentor moderate plus 425cc saline implants filled to 440cc on the right breast and 425cc on the left breast

Before

After

5 4, 33 yo woman, 130 lbs. Mentor high profile 330cc saline implants filled to 360cc.

Before

After

5 3, 33 yo woman, 115 lbs. Mentor moderate plus 350cc silicone implants.

Before

After

5 4, 38 yo woman, 115 lbs. Mentor moderate plus 350cc saline implants filled to 390cc on right and 410cc on left

Before

After

5 4, 40 yo woman, 140 lbs. Mentor moderate plus 400cc saline implants filled to 425cc bilaterally.

Before

After

54 125 lbs. Sub-muscular saline implants with 300cc each side.

Before

After

57 145 lbs. Sub-muscular saline implants with 410cc on both sides.

Before

After

57 155 lbs. Sub-muscular saline implants with 375cc on right and 390cc on left.

Read the original post:
Breast Augmentation Surgery – Home – Edina Plastic Surgery

Breast Reduction Mammoplasty in India at an Economical Budget – Good Herald

Breast reduction Mammoplasty in India with medical tourism packages is available at an economical budget. Largely cost-driven and banking on international goodwill of Indian medicos, the initiative is hoping to benefit both hospitality and healthcare industry. India is tying up with hospitality industry and service providers to help these tourists improve their looks in five star comforts. This is not a critical surgery, so tourists from the US, UK and Canada likes to combine it with travel. They prefer to visit destinations like Goa and Kerala after their surgery. India offers world class cosmetic treatment that is comparable with the UK or US. Furthermore, the high concentration of expatriate Indian medical staff working abroad particularly in the US and UK gives patients confidence in healthcare in India. Breast Reduction Mammoplasty in India is done with the help of most advanced technique available for the treatment. What is Breast reduction Mammoplasty? Breast Reduction Mammoplasty is done to reshape the breasts with the right contours to give a better and fuller view of the breasts. Generally undertaken by women for aesthetic reasons, it boosts the confidence and self image as well as reduces neck and back pain. Breast reduction is generally a problem with women who have large breasts to take part in physical activities apart from the usual back and neck pain. It just not spoils their posture but aesthetically it does not boost their confidence either. Skin problems, skeletal deformities and breathing problems are common for all women who have large breasts. Unusually large breasts can make one extremely self-conscious. This problem exists from teenagers to 80-year-old women. Breast reduction Mammoplasty is best performed when the patient has attained 20 years. The goal is to give the woman smaller, better shaped breasts in proportion with the rest of her body. Why to go for Breast reduction Mammoplasty? Breast reduction Mammoplasty is for women who have large breasts and want to resolve one or more of the following associated problems: Chronic back, neck and shoulder pain Poor posture Skin rash under the breasts Deep grooves in the shoulders from bra strap pressure Restricted levels of activity Self-esteem problems Difficulty wearing or fitting into certain bras and clothing Women who have Breast reduction Mammoplasty span a range of ages, from their teens to their 80s. However, for younger candidates, its usually wise to wait at least till their age of 20 to make sure the breasts have stopped growing. If patient hope to have children, patient need to keep in mind special considerations. Breast reduction Mammoplasty may decrease its ability to breast-feed. And the overall appearance of patients breasts may change after having a baby. Breast reduction Mammoplasty procedure: Techniques for Breast reduction Mammoplasty use to vary, but the most common procedure involves an anchor-shaped incision that circles the areola, extends downward and follows the natural curve of the crease beneath the breast. The surgeon removes excess glandular tissue, fat and skin that move the nipple and areola into their new position. He or she then brings the skin from both sides of the breast down and around the areola, shaping the new contour of the breast. Liposuction may be used to remove excess fat from the armpit area. In most cases, the nipples remain attached to their blood vessels and nerves. However, if the breasts are very large or pendulous, the nipples and areolas may have to be completely removed and grafted into a higher position. (This will result in a loss of sensation in the nipple and areolar tissue.) Stitches are usually located around the areola, in a vertical line extending downward and along the lower crease of the breast. Benefits of Breast reduction Mammoplasty: Oversized, heavy breasts can cause physical pain and unhappiness with self-image. Because of this, many women turn to breast reduction Mammoplasty as a remedy. Relief from Physical Discomfort Associated with Heavy Breasts: Large, heavy breasts can cause strain on a womans body. Especially in cases where a womans breasts are disproportionately oversized compared to her frame, the extra weight of heavy breasts can adversely alter posture and lead to skeletal deformities. In addition to causing back, shoulder and neck pain, the excess burden of heavy breasts may also lead to breathing problems and other serious health issues. By reducing the weight of a womans breasts and making them more proportionate to her frame, Breast reduction Mammoplasty can provide a woman with a chance to correct her posture. The breast reduction mammoplasty can also remove strain on the shoulders, back and neck, reducing overall pain. For many women, these benefits greatly outweigh possible Breast reduction Mammoplasty risks. Breast reduction Mammoplasty in India: A new horizon of the medical field cropping out in India is Breast reduction Mammoplasty, which utilizes some of the state of the art techniques in corrective procedures. India has a talent pool of qualified breast reduction surgeons, a lot of whom have been trained in the US and UK, in specialized areas of breast reduction Mammoplasty. With the recent development of the healthcare infrastructure in India, the best of facilities and equipment are also available with these surgeons. This coupled with the extremely low cost of the surgeries makes India the ideal destination for your breast reduction mammoplasty needs. Breast reduction mammoplasty is done in complete privacy. The cost of breast reduction mammoplasty in the western country is approximately 10 times more than that in India. Significant cost differences exist between U.K. and India when it comes to medical treatment. India is not only cheaper but the waiting time is almost zero. This is due to the outburst of the private sector, which comprises of hospitals and clinics with the latest technology and best practitioners.

For more information on Economical and Low cost plastic Surgery in India visit us at http://www.sanitbahri.in or you can send us your queries at info@sanitbahri.in.You can also call us at +91-9899877779.

Medsurge India, a division Travquest Services India has been the most respectable organization in the Global Healthcare Travel Industry. Sanit Bahri, as an individual healthcare consultant has been instrumental in helping the international patients with low cost medical treatment in India.Sanit Bahri is also working on the Quality of Care Project, which will change the way we look at the reporting of global healthcare statistics and the quality of care available at hospitals around the world.

Photo By sarangib from Pixabay

More here:
Breast Reduction Mammoplasty in India at an Economical Budget – Good Herald